World FDA Approves Travere’s Filspari for Treatment of Focal Segmental Glomerulosclerosis – Contract Pharma Last updated: April 14, 2026 9:31 pm Editorial Staff 6 days ago Share SHARE FDA Approves Travere’s Filspari for Treatment of Focal Segmental Glomerulosclerosis Contract Pharmasource Iran War Live Updates: Oil Prices Spike as Gulf Energy Sites Are Struck – The New York Times How I Got My Career in Foreign Policy: Sebastian Mallaby – Council on Foreign Relations Straight-line winds caused damage across River Valley, NWS confirms – KHBS Counter terrorism police investigate more arson attempts – BBC Crowds pack Imperial Palace for cherry blossom season – nhk.or.jp Share This Article Facebook Email Print Previous Article Trump again rejects Colorado amid accusations of playing politics with disaster aid – Newsday Next Article Times Opinion: Vaccine confusion sets up US for a resurgence of hepatitis B in babies – Chattanooga Times Free Press Leave a Comment Leave a Reply Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment.
